Faculty, Immunology, Mayo Clinic
Location: United States
The biomedical research interests of Kevin D. Pavelko, Ph.D., center on cellular immune responses to infection and cancer. In particular, Dr. Pavelko is interested in understanding how virus vaccine vectors can be used to elicit cytotoxic T cell responses as immunotherapy for the treatment of cancer.
In addition to his independent contributions to the research community, Dr. Pavelko is currently a research scientist in the Immune Monitoring Core at Mayo Clinic. The core provides access to state-of-the-art technologies and strives to further promote an understanding of the human immune system and how it can be used for the treatment and prevention of disease.
Focus areas
Significance to patient care
The discovery that the immune system can control and eliminate cancer has revolutionized approaches to treating this disease. Although this is now widely recognized, increased understanding of how these responses are generated is necessary to identify novel therapeutics and approaches that can be readily used to treat cancer. The development and study of novel vaccine vectors is critical for understanding the best approaches to designing therapies that provide effective, safe and long-lasting protection from cancer and its recurrences.
No Grants Mentioned !!